| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 02/18/2003 | CA2351004C Formulation |
| 02/18/2003 | CA2112237C Cosmetic compositions containing oligosaccharides |
| 02/18/2003 | CA2073042C Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003012105A2 Vegf isoform |
| 02/13/2003 | WO2003011905A1 Novel serine protease |
| 02/13/2003 | WO2003011870A1 Gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011842A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | WO2003011841A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 02/13/2003 | WO2003011839A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011823A2 Crfr1 selective ligands |
| 02/13/2003 | WO2003011396A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 02/13/2003 | WO2003011326A1 Use of long pentraxin ptx3 for treating female infertility |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011314A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 02/13/2003 | WO2003011304A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity |
| 02/13/2003 | WO2003011302A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | WO2003011301A1 As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| 02/13/2003 | WO2003011300A1 As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness |
| 02/13/2003 | WO2003011293A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011282A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 02/13/2003 | WO2003011262A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 02/13/2003 | WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | WO2003011243A1 Invert emulsion containing dhea |
| 02/13/2003 | WO2003011219A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/13/2003 | WO2002094275A8 Use of estrogen compounds to increase libido in women |
| 02/13/2003 | WO2002088146A3 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H-[1,4]DIOXINO[2,3-e]INDOLE |
| 02/13/2003 | WO2002060427A3 Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds |
| 02/13/2003 | WO2002059082A8 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 02/13/2003 | WO2002047719A3 Survical promoting ncam binding and ncam ligand biding compounds |
| 02/13/2003 | WO2002046192A3 Thioether substituted imidazoquinolines |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | US20030032663 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 02/13/2003 | US20030032647 Aromatic nitrogen-containing 6-membered cyclic compounds |
| 02/13/2003 | US20030032630 Use of a 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-kappaB |
| 02/13/2003 | US20030032610 Administering one or more oligonucleotides which share at least 50% nucleotide sequence identity with (TTAGGG)n or oligonucleotides which share at least 50% nucleotide sequence identity with the human telomere overhang repeat. |
| 02/13/2003 | US20030032581 Pharmaceuticals for treating obesity |
| 02/13/2003 | US20030032095 Novel nucleic acid sequences encoding human semaphorin-like polypeptides |
| 02/13/2003 | CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | CA2455833A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | CA2455728A1 As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| 02/13/2003 | CA2455711A1 As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness |
| 02/13/2003 | CA2455358A1 Invert emulsion containing dhea |
| 02/13/2003 | CA2455235A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 02/13/2003 | CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity |
| 02/13/2003 | CA2455179A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | CA2455100A1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454421A1 Use of long pentraxin ptx3 for treating female infertility |
| 02/13/2003 | CA2454414A1 Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 02/13/2003 | CA2452524A1 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 02/13/2003 | CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | CA2448235A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 02/12/2003 | EP1283216A1 Somatostatin analogues binding to all somatostatin receptor subtypes and their use |
| 02/12/2003 | EP1283057A1 Cell proliferation inhibitors |
| 02/12/2003 | EP1283047A1 Method for producing a bioactive substance from blood serum |
| 02/12/2003 | EP1282615A1 Chroman derivatives as estrogenic compounds |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282449A2 Treatment of human papillomavirus (hpv)-infected cells |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282421A2 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain |
| 02/12/2003 | EP1282418A2 Use of pyrazole derivatives for treating infertility |
| 02/12/2003 | EP1282414A2 Felbamate derived compounds |
| 02/12/2003 | EP1282400A2 Pharmaceutical form of administration for peptides, methods for its production and use |
| 02/12/2003 | EP1064262B1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | EP0728147B1 Receptor specific atrial natriuretic peptides |
| 02/12/2003 | CN1396920A 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/12/2003 | CN1396831A Pharmaceutical preparation and method for treatment of diabetes |
| 02/12/2003 | CN1396829A New drug combinations |
| 02/12/2003 | CN1396173A Gene sequence of genital regulation factor enriched in hypothalamus of Epinephelus and its usage |
| 02/12/2003 | CN1395970A Bacterial medical nano suppository for woman and its preparing process |
| 02/12/2003 | CN1395964A Medical usage of simonder wood oil |
| 02/12/2003 | CN1395963A Composite medicine for disinfecting and relieving inflammation |
| 02/12/2003 | CN1395955A Lactogenic medicine and its preparing process and application |
| 02/12/2003 | CN1395942A Long-acting contraceptive |
| 02/12/2003 | CN1395932A Application of estrin/progestogen/anti-progestogen, its composition and medicine box |
| 02/12/2003 | CN1101211C Kidney-nourishing pill and its preparing process |
| 02/12/2003 | CN1101198C Chinese-medicinal capsule for treating impotence |
| 02/12/2003 | CN1101197C Medicated wine capable of treating several disease |
| 02/11/2003 | US6518319 Method of preparing and using compositions extracted from vegetable matter for the treatment of female symptoms |
| 02/11/2003 | US6518295 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance P |
| 02/11/2003 | US6518279 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 02/11/2003 | US6518269 Cancer treatment |
| 02/11/2003 | US6518262 22R-hydroxycholesta-8, 14-diene derivatives for the inhibition of meiosis |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/11/2003 | US6518041 An isolated non-protein-encoding nucleic acid sequence functioning as a hormone response element which binds an androgen- or a progesterone- regulated receptor, comprising: a DNA sequence of the formula (SEQ ID NO:6) (N)x TCTCATTCTGTTCC, |
| 02/11/2003 | US6517843 Recombinant immunogen comprised of an inactivated porcine circovirus-2 |
| 02/11/2003 | CA2205274C Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones |
| 02/11/2003 | CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof |
| 02/11/2003 | CA2085584C Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists |
| 02/11/2003 | CA2071375C Heterocyclic derivatives |
| 02/11/2003 | CA2041818C Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof as pharmaceutical compositions or as performance enhancers |
| 02/06/2003 | WO2003010298A1 'probiotic lactobacillus salivarius strains |
| 02/06/2003 | WO2003010192A2 An inducer of apoptosis |
| 02/06/2003 | WO2003010188A1 Production of high molecular mass lectins |
| 02/06/2003 | WO2003010168A1 4-oxoimidazolidine-2-spiropiperidine derivative |